HBsAg Testing Market Analysis

The market is segmented by application into hospitals, clinics, diagnostic centers, home care, and others, out of which, the hospitals segment is anticipated to hold the largest share in the global Hepatitis B Tests market. This can be accounted to the high preference of people to get treatment from highly trained medical professionals, and presence of large patient pool in a hospital facility. Additionally, on the basis of type, the strips kit segment is predicted to grab the largest share during the forecast period owing to the high affordability, and ease of convenience for testing provided by this type of testing kits. Apart from these, tests conducted by strips kit offers results in a short span of time, which is also assessed to boost the growth of the market segment in the future.

Our in-depth analysis of the global Hepatitis B Tests market includes the following segments:

By Type	Cassettes/Cards Kit Strips Kit
By Application	Hospitals Clinics Diagnostic Centers Home Care Others

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of hepatitis B tests is assessed at USD 1.39 billion.

Hepatitis B Tests Market size was valued at USD 1.33 billion in 2023 and is likely to reach USD 2.77 billion by 2036, registering around 5.8% CAGR during the forecast period i.e., between 2024-2036. The market growth is driven by growing prevalence of hepatitis B, and increasing awareness among about early detection of the disease.

Asia Pacific industry is estimated to dominate majority revenue share by 2036, backed by large number of patients, and growing occurrence of hepatitis in the region.

The major players in the market are Abbott Laboratories, F. Hoffman-La Roche AG, Siemens AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and others.

HBsAg Testing Market Analysis